Management of adult attention deficit hyperactivity disorder in UK primary care: a survey of general practitioners

CORA will be unavailable from 08:00- 09:00 for regular maintenance on Tuesday, 28th May 2019. Apologies for any inconvenience this may cause.

Show simple item record

dc.contributor.author McCarthy, Suzanne
dc.contributor.author Wilton, Lynda
dc.contributor.author Murray, Macey
dc.contributor.author Hodgkins, Paul
dc.contributor.author Asherson, Philip
dc.contributor.author Wong, Ian C. K.
dc.date.accessioned 2016-09-01T08:58:16Z
dc.date.available 2016-09-01T08:58:16Z
dc.date.issued 2013-02-22
dc.identifier.citation McCarthy, S., Wilton, L., Murray, M., Hodgkins, P., Asherson, P. and and Wong, I. C. K. (2013) 'Management of adult attention deficit hyperactivity disorder in UK primary care: a survey of general practitioners', Health and Quality of Life Outcomes 11:22. http://dx.doi.org/10.1186/1477-7525-11-22 en
dc.identifier.volume 11 en
dc.identifier.startpage 22-1 en
dc.identifier.endpage 22-12 en
dc.identifier.issn 1477-7525
dc.identifier.uri http://hdl.handle.net/10468/3049
dc.identifier.doi 10.1186/1477-7525-11-22
dc.description.abstract Background: Compared to existing literature on childhood attention deficit hyperactivity disorder (ADHD), little published adult data are available, particularly outside of the United States. Using General Practitioner (GP) questionnaires from the United Kingdom, this study aimed to examine a number of issues related to ADHD in adults, across three cohorts of patients, adults who received ADHD drug treatment in childhood/adolescence but stopped prior to adulthood; adults who received ADHD drug treatment in childhood/adolescence and continued treatment into adulthood and adults who started ADHD drug treatment in adulthood.Methods: Patients with a diagnosis of ADHD and prescribed methylphenidate, dexamfetamine or atomoxetine were identified using data from The Health Improvement Network (THIN). Dates when these drugs started and stopped were used to classify patients into the three cohorts. From each cohort, 50 patients were randomly selected and questionnaires were sent via THIN to their GPs.GPs returned completed questionnaires to THIN who forwarded anonymised copies to the researchers. Datasets were analysed using descriptive statistics.Results: Overall response rate was 89% (133/150). GPs stated that in 19 cases, the patient did not meet the criteria of that group; the number of valid questionnaires returned was 114 (76%). The following broad trends were observed: 1) GPs were not aware of the reason for treatment cessation in 43% of cases, 2) patient choice was the most common reason for discontinuation (56%), 3) 7% of patients who stopped pharmacological treatment subsequently reported experiencing ADHD symptoms, 4) 58% of patients who started pharmacological treatment for ADHD in adulthood received pharmacological treatment for other mental health conditions prior to the ADHD being diagnosed.Conclusion: This study presents some key findings relating to ADHD; GPs were often not aware of the reason for patients stopping ADHD treatment in childhood or adolescence. Patient choice was identified as the most common reason for treatment cessation. For patients who started pharmacological treatment in adulthood, many patients received pharmacological treatment for comorbidities before a diagnosis of ADHD was made. en
dc.description.sponsorship Shire Development LLC. en
dc.format.mimetype application/pdf en
dc.language.iso en en
dc.publisher BioMed Central en
dc.rights © 2013 McCarthy et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. en
dc.rights.uri http://creativecommons.org/licenses/by/2.0 en
dc.subject Attention deficit hyperactivity disorder en
dc.subject Adult en
dc.subject Stimulant en
dc.subject Primary care en
dc.subject General practitioner en
dc.title Management of adult attention deficit hyperactivity disorder in UK primary care: a survey of general practitioners en
dc.type Article (peer-reviewed) en
dc.internal.authorcontactother Suzanne McCarthy, School of Pharmacy, University College Cork, Cork, Ireland. +353-21-490-3000 Email: s.mccarthy@ucc.ie en
dc.internal.availability Full text available en
dc.description.version Published Version en
dc.contributor.funder Shire Development LLC., United States en
dc.description.status Peer reviewed en
dc.identifier.journaltitle Health and Quality of Life Outcomes en
dc.internal.IRISemailaddress s.mccarthy@ucc.ie en


Files in this item

This item appears in the following Collection(s)

Show simple item record

© 2013 McCarthy et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Except where otherwise noted, this item's license is described as © 2013 McCarthy et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
This website uses cookies. By using this website, you consent to the use of cookies in accordance with the UCC Privacy and Cookies Statement. For more information about cookies and how you can disable them, visit our Privacy and Cookies statement